| pubmed-article:2970527 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2970527 | lifeskim:mentions | umls-concept:C0237798 | lld:lifeskim |
| pubmed-article:2970527 | lifeskim:mentions | umls-concept:C0024399 | lld:lifeskim |
| pubmed-article:2970527 | lifeskim:mentions | umls-concept:C0034798 | lld:lifeskim |
| pubmed-article:2970527 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2970527 | pubmed:dateCreated | 1988-9-26 | lld:pubmed |
| pubmed-article:2970527 | pubmed:abstractText | D1 and D2 dopamine receptors were characterized in the caudate-putamen region of nonhuman primate brains (Macaca fascicularis). D1 dopamine receptors were identified with [3H]SCH 23390 and D2 receptors with [3H]-spiperone. Scatchard analysis of [3H]SCH 23390 saturation data using washed membranes revealed a single high-affinity binding site (KD, 0.352 +/- 0.027 nM) with a density (Bmax) of 35.7 +/- 2.68 pmol/g original wet tissue weight (n = 10). The affinity of [3H]spiperone for the D2 site was 0.039 +/- 0.007 nM and the density was 25.7 +/- 1.97 pmol/g original wet tissue weight (n = 10). D1 and D2 receptors in nonhuman primates may be differentiated on the basis of drug affinities and stereoselectivity. In competition experiments, RS-SKF 38393 was the most selective D1 agonist, whereas (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] was the most selective D2 agonist. Apomorphine was essentially nonselective for D1 or D2 binding sites. Of the antagonists, R-SKF 83566 and SCH 23390 were the most selective for the D1 site, whereas YM-09151-2 was the most selective for the D2 site. cis-Flupentixol and (S)-butaclamol were the least selective dopamine antagonists. D1 receptors bound benzazepine antagonists (SCH 23390/SCH 23388, R-SKF 83692/RS-SKF 83692) stereoselectively whereas D2 receptors did not. Conversely D2 receptors bound (S)-sulpiride and (+)-PHNO more potently than their enantiomers whereas D1 receptors showed little stereoselectively for each of these isomeric pairs. These binding characteristics may be utilized for evaluation of individual receptor function in vivo. | lld:pubmed |
| pubmed-article:2970527 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2970527 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2970527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2970527 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2970527 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:2970527 | pubmed:issn | 0022-3042 | lld:pubmed |
| pubmed-article:2970527 | pubmed:author | pubmed-author:SpealmanR DRD | lld:pubmed |
| pubmed-article:2970527 | pubmed:author | pubmed-author:MadrasB KBK | lld:pubmed |
| pubmed-article:2970527 | pubmed:author | pubmed-author:CanfieldD RDR | lld:pubmed |
| pubmed-article:2970527 | pubmed:author | pubmed-author:FaheyM AMA | lld:pubmed |
| pubmed-article:2970527 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2970527 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:2970527 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2970527 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2970527 | pubmed:pagination | 934-43 | lld:pubmed |
| pubmed-article:2970527 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:meshHeading | pubmed-meshheading:2970527-... | lld:pubmed |
| pubmed-article:2970527 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2970527 | pubmed:articleTitle | D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis). | lld:pubmed |
| pubmed-article:2970527 | pubmed:affiliation | Harvard Medical School, New England Regional Primate Research Center, Southborough, MA 01772. | lld:pubmed |
| pubmed-article:2970527 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2970527 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2970527 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2970527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2970527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2970527 | lld:pubmed |
